Absci Corporation’s ABSI share price has surged by 17.57%, which has investors questioning if this is right time to sell.

According to Benzinga Pro, Absci's peer group average for short interest as a percentage of float is 12.92%, which means the company has more short interest than most of its peers. Did you know that ...

Absci Co. (NASDAQ:ABSI – Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 15,490,000 shares ...

BofA Securities made adjustments to its outlook on AMD (NASDAQ:AMD) shares, lowering the price target to $135 from the previous $155, while keeping a Neutral stance on the company. According to ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

Shares of Under Armour, Inc. (NYSE:UAA – Get Free Report) have earned a consensus recommendation of “Hold” from the ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug discovery workloads, including a biologic drug design platform using ...

Cathie Wood's ARK ETFs have made their daily trades public for Monday, February 3rd, 2025, with a mix of strategic buys and sells across various sectors. The most significant move of the day was the ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.